Faecalibacterium prausnitzii-derived extracellular vesicles alleviate chronic colitis-related intestinal fibrosis by macrophage metabolic reprogramming
Faecalibacterium prausnitzii (F. prausnitzii) has been recognized for its various intestinal and extraintestinal benefits to human. And reduction of F. prausnitzii has been linked to an increased risk of intestinal fibrosis in patients of Crohn's disease (CD). In this study, oral administration...
Saved in:
Main Authors: | Ying Wang (Author), Linjie Li (Author), Shuze Chen (Author), Zonglin Yu (Author), Xuefeng Gao (Author), Xiaojie Peng (Author), Qiujuan Ye (Author), Zitong Li (Author), Weihao Tan (Author), Ye Chen (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Possible Benefits of Faecalibacterium prausnitzii for Obesity-Associated Gut Disorders
by: Tatiani Uceli Maioli, et al.
Published: (2021) -
A higher bacterial inward BCAA transport driven by Faecalibacterium prausnitzii is associated with lower serum levels of BCAA in early adolescents
by: Sofia Moran-Ramos, et al.
Published: (2021) -
Reprogramming Extracellular Vesicles for Protein Therapeutics Delivery
by: Leyla A. Ovchinnikova, et al.
Published: (2021) -
Dental stem cell-derived extracellular vesicles as promising therapeutic agents in the treatment of diseases
by: Ye Li, et al.
Published: (2022) -
The Therapeutic Effect of iMSC-Derived Small Extracellular Vesicles on Tendinopathy Related Pain Through Alleviating Inflammation: An in vivo and in vitro Study
by: Zhu Z, et al.
Published: (2022)